Skip to main content
. 2021 Sep 14;11(9):e049376. doi: 10.1136/bmjopen-2021-049376

Table 3.

Assumptions for power calculation

Outcome Prevalence in screening group Prevalence in COVID-19 group Sample size screening group Sample size COVID-19 group
Pre-eclampsia 6% 12% 511 256
Thrombosis 0.13% 2% 613 306
Small for gestational age (below 10th percentile) 10% 20% 199 199
Preterm delivery 6% 12% 511 256
Neurological and/or neurodevelopmental disorders 1% 4% 581 290